Summary:
- The article discusses a potential policy change by the National Institutes of Health (NIH) to restrict the use of N-of-1 studies (NOS1) for all but emergency purposes.
- N-of-1 studies are a type of clinical trial where a single patient is the focus, rather than a larger group, allowing for personalized treatment approaches.
- The article suggests that this policy change could have significant implications for researchers and patients, as it may limit the ability to conduct these specialized studies and access personalized treatments.